IM Cannabis Corp. (NASDAQ:IMCC) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET
Company Participants
Anna Taranko - Director of Investor and Public Relations
Oren Shuster - Chief Executive Officer
Uri Birenberg - Chief Financial Officer
Conference Call Participants
Operator
Good morning, and welcome to IM Cannabis' Third Quarter 2024 Earnings Conference Call. Today's conference call is being recorded.
At this time, I would like to turn the conference call over to Anna Taranko, Director of Investor and Public Relations. Anna?
Anna Taranko
Good morning, and thank you, operator. Joining me for today's call are IM Cannabis' Chief Executive Officer, Oren Shuster, and Chief Financial Officer, Uri Birenberg. The earnings press release that accompanies this call is available on the Investor Relations section of our website at investors.imcannabis.com.
Today's call will include estimates and other forward-looking information and statements, including statements concerning future results of operations, economic conditions and anticipated courses of actions, and are based on assumptions, expectations, estimates and projections as the date hereof. This information may involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied by such statements.
Factors that could cause or contribute to such differences are described in detail in the Company's most recent filings available on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov. Furthermore, certain non-IFRS measures will be referred to during this call, and the term non-IFRS adjusted EBITDA loss will hereafter be referred to as adjusted EBITDA loss. Any estimates or forward-looking information or statements provided are accurate only as of the date of this call, and the Company undertakes no obligation to publicly update any forward-looking information or statements or supply new information regarding the circumstances after the date of this call. Please also note that all references on this call reflect currency in Canadian dollars unless otherwise stated.
With that, it is my pleasure to turn the call over to Oren Shuster, CEO of IM Cannabis. Oren, please go ahead.
Oren Shuster
Thank you, Anna. Good morning, everyone, and thank you for joining us today. In the Q3, we had a clear focus to build a solid foundation to deliver accelerated growth in Germany in 2025. That said as the medical cannabis company active in Israel and in Germany, I will start with the quick overview of the development of the German market and our performance there before explaining the progress we made to position the company for 2025.